FDA Compounding Summit With States: Strategic Step Forward Or 50 More Cooks?
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has yet to define where it would like to draw the line between federal and state oversight of compounding pharmacies, but the Dec. 19 could be the first step to consensus on the responsibilities that each regulator should take.